Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer. The company is based in New Haven, Connecticut.
Industry, Sector and Symbol
Industry Analytical instruments
Sub-IndustryN/A
SectorMedical
Phone203-787-7888
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$1.72 million
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Precipio (NASDAQ:PRPO) Frequently Asked Questions
What is Precipio's stock symbol?
Precipio trades on the NASDAQ under the ticker symbol "PRPO."
When did Precipio's stock split? How did Precipio's stock split work?
Precipio shares reverse split on Tuesday, June 6th 2017. The 1-30 reverse split was announced on Thursday, May 25th 2017. The number of shares owned by shareholders was adjusted after the market closes on Monday, June 5th 2017. An investor that had 100 shares of Precipio stock prior to the reverse split would have 3 shares after the split.
How were Precipio's earnings last quarter?
Precipio Inc (NASDAQ:PRPO) issued its quarterly earnings results on Thursday, August, 23rd. The biotechnology company reported ($0.15) earnings per share (EPS) for the quarter, missing the Thomson Reuters' consensus estimate of $1.93 by $2.08. The biotechnology company had revenue of $0.82 million for the quarter. Precipio had a negative net margin of 610.39% and a negative return on equity of 149.24%. View Precipio's Earnings History.
Has Precipio been receiving favorable news coverage?
Media headlines about PRPO stock have trended somewhat negative recently, InfoTrie reports. InfoTrie identifies positive and negative media coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of companies on a scale of negative five to five, with scores nearest to five being the most favorable. Precipio earned a news sentiment score of -1.5 on InfoTrie's scale. They also gave news coverage about the biotechnology company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the stock's share price in the near future.
Are investors shorting Precipio?
Precipio saw a decline in short interest in February. As of February 15th, there was short interest totalling 389,507 shares, a decline of 41.9% from the January 31st total of 670,802 shares. Based on an average daily volume of 2,384,778 shares, the days-to-cover ratio is presently 0.2 days. Approximately 1.4% of the company's shares are sold short. View Precipio's Current Options Chain.
Who are some of Precipio's key competitors?
Some companies that are related to Precipio include Illumina (ILMN), Agilent Technologies (A), Waters (WAT), Mettler-Toledo International (MTD), PerkinElmer (PKI), Bio-Rad Laboratories (BIO.B), Bio-Rad Laboratories (BIO), Bruker (BRKR), Coherent (COHR), Horiba (HRIBF), Pacific Biosciences of California (PACB), Accelerate Diagnostics (AXDX), Fluidigm (FLDM), Quanterix (QTRX) and Eyepoint Pharmaceuticals (EYPT).
What other stocks do shareholders of Precipio own?
Who are Precipio's key executives?
Precipio's management team includes the folowing people:
- Mr. Ilan Danieli, Founder, Pres, CEO & Director (Age 47)
- Mr. Carl R. Iberger, CFO & Sec. (Age 66)
- Mr. Ahmed Zaki Sabet, Chief Operating Officer (Age 33)
- Mr. Douglas Sites, VP of Sales
- Mr. Ayman Mohamed, Sr. VP of R&D and Laboratory Operations (Age 34)
How do I buy shares of Precipio?
Shares of PRPO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Precipio's stock price today?
One share of PRPO stock can currently be purchased for approximately $0.15.
How big of a company is Precipio?
Precipio has a market capitalization of $4.56 million and generates $1.72 million in revenue each year.
What is Precipio's official website?
How can I contact Precipio?
Precipio's mailing address is 4 Science Park, New Haven CT, 06511. The biotechnology company can be reached via phone at 203-787-7888 or via email at [email protected]
MarketBeat Community Rating for Precipio (NASDAQ PRPO)
MarketBeat's community ratings are surveys of what our community members think about Precipio and other stocks. Vote "Outperform" if you believe PRPO will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PRPO will underperform the S&P 500 over the long term. You may vote once every thirty days.
